Combination GRA and SGLT-2i Treatment in Type 1 Diabetes

NCT04545411 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: Dapagliflozin 10 MG [Farxiga]
DRUG: REMD-477
DRUG: Placebo

Sponsor

University of California, San Diego

Collaborators

[object Object]
[object Object]
[object Object]